FDAnews Drug Daily Bulletin

ADAMS RESPIRATORY PRICES SECONDARY PUBLIC OFFERING

Dec. 12, 2005
A A

Adams Respiratory Therapeutics Inc. (ARXT.O: Quote, Profile, Research) on Friday said it has priced its secondary offering of about 5.7 million common shares at $43.75 per share. The company said in a statement the selling stockholders have granted the underwriters an option to purchase up to an additional 849,112 shares to cover over-allotments.

Reuters (http://today.reuters.com/investing/financeArticle.aspx?type=newIssuesNews&storyID=URI:urn:newsml:reuters.com:20051209:MTFH52886_2005-12-09_13-42-15_WNA6055:1)